Search
 

Why pharma may not fear the latest drug-price probe

Things are about to get awkward for makers of drugs targeting multiple sclerosis.

By Max Nisen | Updated on August 18, 2017
House Democrats sent letters to prominent biopharma companies demanding information.

(Bloomberg Gadfly) – Things are about to get awkward for makers of drugs targeting multiple sclerosis.

On Thursday afternoon, House Democrats sent letters to prominent biopharma companies that sell MS treatments including Biogen Inc., Novartis AG, Roche Holding AG, and Sanofi, demanding a variety of information about the large and, according to the letters, often seemingly concerted price hikes they have taken as part of an “in-depth investigation.” As would be expected, the news sparked a decline in the drugmakers’ shares.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Recommended Stories

BenefitsPRO Broker Expo 2025 (BPRO)Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information
 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2024 ALM Global, LLC. All Rights Reserved.